DEMIANA ATTALLAH: Open Payments
NPI 1164104717 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $159 |
| ABBVIE INC. | 2 | $46 |
| GENZYME CORPORATION | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Radius Health, Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Sandoz Inc. | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Bimzelx, RINVOQ, KEVZARA, SAPHNELO, COSENTYX, Tymlos, STRENSIQ, OTEZLA.
Industry payments across TN — which companies pay providers there.
